Comparison of the effectiveness of erlotinib, gefitinib, and afatinib for treatment of non-small cell lung cancer in patients with common and rare EGFR gene mutations

Journal

  • Oncology Letters

    Oncology Letters 13 (6), 4433-4444, 2017-04-03

    Spandidos Publications

Citations (2)*help

See more

Details 詳細情報について

Report a problem

Back to top